CST4 and periodontitis: [43] reported that cystatin SN expression in a group of treated periodontitis patients (reduced but stable periodontium) was re‐established to levels comparable to that of periodontally healthy subjects, suggesting that this protein could be used not only as a biomarker to support the diagnosis of periodontitis but also to monitor treatment response and risk for disease progression [78].